{"id":"NCT01435616","sponsor":"Eli Lilly and Company","briefTitle":"A Study in Patients With Type 2 Diabetes Mellitus","officialTitle":"A Comparison of LY2605541 Versus Insulin Glargine as Basal Insulin Treatment in Combination With Oral Anti-Hyperglycemia Medications in Insulin-Naive Patients With Type 2 Diabetes Mellitus: A Double-Blind, Randomized Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2014-01","completion":"2014-01","firstPosted":"2011-09-16","resultsPosted":"2018-04-13","lastUpdate":"2018-04-13"},"enrollment":1538,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"Glargine","otherNames":[]},{"type":"DRUG","name":"LY2605541","otherNames":[]}],"arms":[{"label":"LY2605541","type":"EXPERIMENTAL"},{"label":"Glargine","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is:\n\n* To compare blood sugar control on LY2605541 with insulin glargine after 52 weeks of treatment.\n* To compare the rate of night time low blood sugar episodes on LY2605541 with insulin glargine during 52 weeks of treatment.\n* To compare the number of participants on LY2605541 reaching blood sugar targets without low blood sugar episodes at night to those taking insulin glargine after 52 weeks of treatment.\n* To compare the rate of low blood sugar episodes on LY2605541 with insulin glargine after 52 weeks of treatment","primaryOutcome":{"measure":"Change From Baseline to 52 Week Endpoint in Hemoglobin A1c (HbA1c)","timeFrame":"Baseline, 52 weeks","effectByArm":[{"arm":"LY2605541","deltaMin":-1.55,"sd":0.03},{"arm":"Glargine","deltaMin":-1.25,"sd":0.04}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":167,"countries":["United States","Argentina","Australia","Brazil","Canada","Finland","Germany","Greece","Hungary","Israel","Italy","Lithuania","Mexico","New Zealand","Poland","Puerto Rico","Romania","Russia","Slovakia","South Africa","Spain","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36542287","29167192","28587667","28417532"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":105,"n":1003},"commonTop":["Nasopharyngitis","Headache","Upper respiratory tract infection","Back pain","Diarrhoea"]}}